for January 2019
WAVE OF DISEASED ILLEGALS BROUGHT TO YOU BY DEMS!
— ♦️GAYE GALLOPS♦️ (@gaye_gallops) January 17, 2019
They RAIL about unvaccinated kids being THE ENEMY OF THE PUBLIC
THEY LOVE BIG PHARMA MONEY!
Gov Officials at Border see a SURGE OF INFECTIOUS DISEASES in kids,adult ILLEGALS
NANCY?
CHUCK?
NOT A PEEP? https://t.co/u7TqSQ8gN8
Vaccination against measles is crucial to avoid outbreaks like the ones hitting Europe & the U.S. Even more important because the virus erases the immune system’s memory, leaving patients vulnerable to other infectious diseases for up to 3 years afterward https://t.co/97q2rvtaU8 pic.twitter.com/Ss2OGCsUy6
— Massimo (@Rainmaker1973) January 24, 2019
DEMS DEMAND VACCINATIONS FOR AMERICANS YET ALLOW DISEASES TO COME THROUGH THE BORDER! Illegal migrants bringing a wave of infectious DISEASE into the United States while Democrats demand mass vaccinations of Americans! #SecureOurBorder https://t.co/Q1tQoznQpx
— Rose (@rosedixontx) January 16, 2019
🔥🔥NEW! December is over, did you miss anything? Here is our monthly top NEW articles in the fields of antimicrobial stewardship & infectious Diseases from @IDstewardship & I 📲 https://t.co/8zMWGR63ni pic.twitter.com/7sbr5xidzV
— Antibiotic Steward (@ABsteward) January 3, 2019
This may be the most chilling sentence I've ever read in a paper:
— Jon Otter (@jonotter) January 30, 2019
"Among the 498 patients [in a Greek ICU], 226 [45%] were rectally colonized by carbapenem-resistant Klebsiella pneumoniae (CRKP), 48 [10% of all patients] of whom developed a CRKP BSI."https://t.co/6BCfNsMKR8
NEW🔥 Multicenter cohort study
— Antibiotic Steward (@ABsteward) January 23, 2019
No difference in 30 day mortality in hospitalized patients who received oral step-down vs continued parenteral therapy for treatment of Enterobacteriacea BSI
IV 5 d then Switch to PO 🤔
I wonder what was the duration 7 Vs 14
https://t.co/3Zs7cphWzd pic.twitter.com/MwxhQxiMGM
NEW. 🔥In AAC @ASMicrobiology :Adjuvant β-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Does β-lactam class matter? Awaiting for CAMERA 2@Guru_JoshD https://t.co/Y6DgRCnnHT pic.twitter.com/1VHWgyjThw
— Antibiotic Steward (@ABsteward) January 8, 2019
NEW 🔥 in CID
— Antibiotic Steward (@ABsteward) January 14, 2019
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study.
C/EI of beta-lactams in cirrhotic may improve outcomes & facilitate earlier discharge. Awaiting for BLING RCT 🤔https://t.co/s6xuQD9h4N pic.twitter.com/oCzfhkCcYL
Systematic Review of the Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening for MRSA Pneumonia. NEW 🔥in Annals of Pharmacotherapy by @Tribidibidy
— Antibiotic Steward (@ABsteward) January 2, 2019
@DrDrayMBA @klusardi41 https://t.co/9J5z26NqNx pic.twitter.com/TuuKCUSfFL
NEW 🔥in @AJHPOfficial Pharmacist-led antimicrobial stewardship program in an urgent care setting. @KaseyPharmD @LisaIDpharmD https://t.co/7hEXFuXuZe pic.twitter.com/iag4cvVytz
— Antibiotic Steward (@ABsteward) January 18, 2019
Is a shorter antibiotic course for neonatal pneumonia a safe opportunity for antimicrobial stewardship? Results of a new, small RCT suggest that might be the case: https://t.co/HBXcb4Bsib #ebneoalerts #neoEBM pic.twitter.com/ue8A1AFizm
— Evidence-Based Neo (@EBNEO) January 11, 2019
NEW🔥 Retrospective cohort study in CID :Beta-lactam and daptomycin combination therapy failed to reduce mortality rates in patients with MSSA bacteremia. Awaiting for results of DASH RCT @DrToddLee https://t.co/iFOK8gBV8c pic.twitter.com/QaEPYsW8TQ
— Antibiotic Steward (@ABsteward) January 7, 2019
Aspiration pneumonia and pneumonitis: a spectrum of infectious/noninfectious diseases affecting the lung. A NEW🔥 Review article. https://t.co/Rg8Jq4AMFF pic.twitter.com/Al7WbUZGKE
— Antibiotic Steward (@ABsteward) January 24, 2019
New🔥 review article by the expert in PK PD @@jasonroberts_pk Intravenous fosfomycin for the treatment of multidrug resistant pathogens: what is the evidence on dosing regimens? A must read article. @nabrivahttps://t.co/D7GAkadghU pic.twitter.com/KZri5TAEFP
— Antibiotic Steward (@ABsteward) January 23, 2019
NEW 🔥🔥🔥OVIVA finally published :Oral antibiotics non-inferior to intravenous in osteomyelitis. A definite practice-changing study, in @NEJM by @ThwaitesGuy @PhilipBejon @raseaton66 team. VIVA #OVIVA. https://t.co/pStcSOvrxw
— Antibiotic Steward (@ABsteward) January 31, 2019
Great editorial @hboucher3https://t.co/lV7cOUIM0U pic.twitter.com/Eay3WaTbD1
NEW🔥🔥 in CID by @BradSpellberg
— Antibiotic Steward (@ABsteward) January 7, 2019
Short Course Antibiotic Therapy—Replacing Constantine Units with “Shorter Is Better” https://t.co/fKHRqZVrqO pic.twitter.com/EDOZmdHm6H
WHO’s Top 10 Threats to global health:
— Storm 🕊 (@StormResist) January 18, 2019
Climate change
Diseases such as cardiac or diabetes
Flu epidemics
War/conflict torn areas
Antibiotic resistance
Ebola and infectious diseases
Poor access to healthcare
Anti-Vaxxers
Dengue- insect borne illness
HIVhttps://t.co/wcTpfhrIXw
Does the addition of antibiotic therapy result in better outcomes among patients hospitalized for an asthma exacerbation and treated with corticosteroids, ? A NEW 🔥large cohort study Just published in @JAMA_current @JAMAInternalMed https://t.co/6eEtIefRmW pic.twitter.com/PVASL4qu4r
— Antibiotic Steward (@ABsteward) January 28, 2019
In Case U Missed T
— Antibiotic Steward (@ABsteward) January 24, 2019
NEW🔥 Review Article
Procalcitonin to guide antibiotic decision making. https://t.co/aO0DZkgRnk pic.twitter.com/vXIz0VAh43
This. Is. Excellent. Work. 🙌🏼
— Tim Gauthier (@IDstewardship) January 19, 2019
New in @AJHPOfficial about coming together for a common cause and championing stewardship for a 33-hospital system...
📲 https://t.co/G5gmqXst9D#Antibiotics #ABXstewardship #SaveABX #DefendABX pic.twitter.com/I53okvDNak
In case you missed it
— Antibiotic Steward (@ABsteward) January 5, 2019
A new review article in IJAA
The dosing and monitoring of vancomycin – what is the best way forward? #antibioticsteward #idprn https://t.co/DDOtSR7VeN pic.twitter.com/JHk2OHUZDg
Many patients report they are allergic to penicillin but few have clinically significant reactions. Thoughtful evaluation of allergy before deciding NOT to use penicillin/β-lactams is an important tool for antimicrobial stewardship. @SHEA_Epi @IDSAInfo https://t.co/lqMDxMqGpv
— Preeti Malani (@PreetiNMalani) January 15, 2019
NEW 🔥 In IJAA Fluoroquinolone-based versus beta lactam-based regimens for complicated intra-abdominal infections: a meta-analysis of randomized controlled trials. https://t.co/WBxOTqwGlq pic.twitter.com/tS62zAFU29
— Antibiotic Steward (@ABsteward) January 10, 2019
🤔 What do surgeons have to 🗣 say about antimicrobial stewardship?
— Tim Gauthier (@IDstewardship) January 9, 2019
Dr. Heather Evans @heatherevansmd is interviewed here by @krutu8 and I about this important topic... 💊🔪🦠😷...
📲 https://t.co/cNt3n0DK6f #Surgery #SurgicalCare #SaveABX #STOPIT pic.twitter.com/TRYsbaiRcn
Final version of Celine Pulcini's 'Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach' now available https://t.co/hsUwXwnYvv @CIDRAP-ASP @ESGAP_ABS @NCAS_Aus @fidssa1
— Marc Mendelson (@SouthAfricanASP) January 4, 2019
NEW: @TJCommission proposes new requirements for outpatient antimicrobial stewardship in Ambulatory Health Care and Office-Based Surgery programs. Review the 6 draft elements and provide your comments by 2/18/19. https://t.co/y6pq1iN4nA #OutptASP pic.twitter.com/nb3iuJqiLT
— SIDP (@SIDPharm) January 16, 2019
#10YearChallenge 😭
— Antibiotic Tweets (@khalideljaaly) January 19, 2019
Let’s do better #AntibioticStewardship 🙏🏼 pic.twitter.com/qHpgAGtez6
Treat endocarditis for 4 weeks or 6 weeks? Or something else entirely? Wading into the thorny duration of antimicrobial therapy debate, inspired by recent papers and @BradSpellberg @Darcy_ID_doc @Guru_JoshD @SAIRABT et al. https://t.co/KqoNje4fwz
— Paul Sax (@PaulSaxMD) January 23, 2019
Scientists find a previously unknown resistance mechanism in #Listeria monocytogenes. When these bacteria come into contact with antibiotics that target ribosomes, they can split their ribosomes in two to recycle them and restart protein production.https://t.co/gTMjohOeG5 pic.twitter.com/SnDQQjwkAO
— Microbes&Infection (@MicrobesInfect) January 2, 2019
Our new study investigating the cultural and contextual determinants of #antimicrobialstewardship programmes across low-, middle- and high-income countries— 🇮🇳 🇬🇧 🇫🇷 🇳🇴 🇧🇫 @PLOSONE @ISID_org @ECCMID @ESRC https://t.co/GcW1xNbcOX
— Esmita Charani (@e_charani) January 16, 2019
Just published: A systematic review of interventions to improve antimicrobial stewardship for older people in #Carehomes. Great work from our PhD researcher @Hoa_Q_Nguyen #antibioticresistance #research https://t.co/TuEdybtT5o
— Primary Care Research QUB Pharmacy (@QUBPrimaryCare) January 28, 2019
'Antimicrobial Stewardship for Africa' - an online course from @BSACandJAC on @FutureLearn. Join now: https://t.co/KKVwL4iIwD
— Ayodeji Matuluko (@Pharm_ay) January 7, 2019
Cardiac events after macrolides or fluoroquinolones in patients hospitalized for CAP: post-hoc analysis of a cluster-randomized trial. NEW In BMC infectious Diseases by @douwefp @MarcBonten https://t.co/uBQUGwrXqu pic.twitter.com/XuaXjwyMAV
— Antibiotic Steward (@ABsteward) January 10, 2019
The dosing and monitoring of vancomycin - what is the best way forward? Something to ponder and consider.... https://t.co/Mcdf4zyR0W #solveitwithscience #CMUS #TDM #antimicrobialstewardship pic.twitter.com/HRxLZninIf
— Carl Kirkpatrick (@CarlkRx) January 14, 2019
‘UK launches 5-year antibiotic resistance plan to fight “urgent” global threat’ #StopSuperbugs https://t.co/Ol9Vv0c5hG
— Antibiotic Action (@TheUrgentNeed) January 24, 2019
NEW🔥in @bmj_latest @jeffreylinder @kaopingchua
— Antibiotic Steward (@ABsteward) January 17, 2019
Appropriateness of outpatient antibiotic prescribing among privately insured US patients ICD-10-CM based cross sectional study
1 in 4 Abx prescription were inappropriate😱
1 in 7 pts received inappropriate ABhttps://t.co/xzDuGI4oAj pic.twitter.com/cBXLQJNBco
FMT > fidaxomicin for recurrent C diff. I’m a believer in the power of 💩. https://t.co/Fbbme5w80l pic.twitter.com/cUHWYzR9Nq
— Nick Bennett (@nbennett04) January 9, 2019
Genomics-based study identifies identical antimicrobial resistance genes found in livestock and human isolates, but with limited overlap in the mobile elements carrying these genes @mbiojournal https://t.co/00LJhLFoJ4 pic.twitter.com/cXTNGg0W2u
— ASM (@ASMicrobiology) January 29, 2019
We're hiring a #postdoc, come #science with us!
— nita bharti (@nitanother) January 24, 2019
Got experience with GIS, R, and Python?
Use it on health, infectious diseases, bats, and Hendra virus spillover in Australia.@bat1health #dreamteam @rainamontana @bahanbug @ali_bat @PeterPjh18 #sciencejobshttps://t.co/yLGUxb82Mo pic.twitter.com/PoAgnTmucv
NEW 🔥MONCAY RCT just published in CID Dolutegravir monotherapy Vs dolutegravir/abacavir/lamivudine for virologically suppressed people living with chronic HIV infection
— Antibiotic Steward (@ABsteward) January 2, 2019
Also editorial: Antiretroviral monotherapy for HIV. Game over or future perspectives? https://t.co/E8hjgX4qvy pic.twitter.com/bcd72DfIbP
Why is C. difficile infection so hard to differentiate from colonization? We run down advantages and limitations of different CDI diagnostic tests, in the latest Bugs & Drugs article: https://t.co/1SiBfhyp3j #ASMClinMicro pic.twitter.com/0tRfxUUPFH
— ASM (@ASMicrobiology) January 21, 2019
Impressive multi-centre, multi-national study reinforcing that jet-air dryers aren't a brilliant idea in clinical areas due to the risk of aerosolising bacteria https://t.co/a1b9xxJpT4 @jhieditor
— Jon Otter (@jonotter) January 8, 2019
New! Want to 🧠 learn more about vancomycin dosing tools? You can here from @DoseMeApp founder Dr. Robert McLeay...
— Tim Gauthier (@IDstewardship) January 15, 2019
📲 https://t.co/oCYtRz0Kas#PkPd #vancomycin #ClinicalDecisionSupport #Antibiotics #AUCMIC #DoseMe #DoseMeRx pic.twitter.com/Jyeabo0I1w
It is so scary... From the European Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections #EUJAMRAI, we have created a collection of documents about implementation of antibiotic stewardship at different level of care: https://t.co/UXitF2XhYn
— EU-JAMRAI (@EUjamrai) January 21, 2019
Let's fight!
NEW 🔥 in CID
— Antibiotic Steward (@ABsteward) January 14, 2019
Outpatient Parenteral Antibiotic Treatment (OPAT) for Infective Endocarditis: a Prospective Cohort Study From the GAMES Cohort.🇪🇸#opat https://t.co/6DkSgxgkmX pic.twitter.com/Hwb8QlvUCY
New #AACJournal minireview: new treatment options against carbapenem-resistant A. baumanii (CRAB) infections #ASMClinMicro https://t.co/CYvyxpGnkN pic.twitter.com/eeL96e14Mb
— ASM (@ASMicrobiology) January 21, 2019
📄 Looking forward to reading this one...https://t.co/pbcJiohQyH #Daptomycin
— Tim Gauthier (@IDstewardship) January 1, 2019
Hold the statin? Cut statin dose in half? Just monitor?.... since this is ID, the answer must be “it depends” right? pic.twitter.com/XAzwh0UfCK
NEW review article
— Antibiotic Steward (@ABsteward) January 18, 2019
New antibiotics for CAP. Dr. Kollef and @betts_kevhttps://t.co/n9uMN8Ryfs pic.twitter.com/2fsAcy8x1w
I am very pleased that this paper is now published - have a read to see how we used the TDF to examine antimicrobial stewardship in community pharmacy https://t.co/xNKkUFr6gX@TARGETabx @nickafrancis @DrDianeAshiru @AnnaSallis @Cliodna_McNulty
— Leah Ffion Jones (@miss_leah_jones) January 14, 2019
Lots of great information on #InfectionPrevention and #AntimicrobialStewardship in this free online guide from @ISID_org! https://t.co/15K5o6IH6I @gonzalobearman @shaheenmehtar pic.twitter.com/2n2cWXGHNG
— Mike Stevens (@Dr_Mike_Stevens) January 6, 2019
'The depressing "10-year challenge" against antibiotic resistance: Doctors share image to show germs no longer respond to drugs that worked a decade ago' #StopSuperbugs https://t.co/FVhZbsbsp2
— Antibiotic Action (@TheUrgentNeed) January 22, 2019
Created by Cameron Forbes. Last updated November 10, 2019 at 15:41 EST.